Pharmacokinetic Profiling Evaluation of Ruditapes philippinarum Polysaccharide
Marine Drugs · 11.08.2026 · 24 (8) · 278
DOI: 10.3390/md24080278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 11.08.2026. Verfasst von Meng-Yue Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Qingdao University, Qingdao 266071, China. Hauptthemen laut MEDLINE: Polysaccharides, Bivalvia. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taishan Industrial Leading Talents Project-Blue Talent Special (2021), Natural Science Foundation of Shandong Province, Taishan Industrial Leading Talents Project—Blue Talent Special.
Abstract (Originalsprache)
Oral administration represents the primary route for administering polysaccharides. Pharmacokinetics serves as a critical bridge between the administration of polysaccharides and the manifestation of their bioactivities. However, the pharmacokinetic behavior of polysaccharides remains poorly understood. This study aimed to investigate the in vivo pharmacokinetics of an orally administered Ruditapes philippinarum polysaccharide (ERPP), including its plasma concentration–time profile, tissue distribution, and excretion. Moreover, a sensitive quantitative method was developed using 5-DTAF as a fluorescent probe to quantify ERPP levels in rat plasma and tissues. The results revealed that ERPP was absorbed in the gut (Tmax = 3 h), reaching a peak concentration (Cmax) of 22.7 ± 2.7 mg/L. Subsequently, it predominantly accumulated in the kidneys, liver, and lungs. Complementarily, near-infrared fluorescence (NIR) imaging provided real-time qualitative visualization of ERPP-Cy5.5 tissue distribution, corroborating the organ-level accumulation pattern observed in the quantitative study. Excretion studies over a 24 h observation window indicated that ERPP was primarily excreted via feces, with 45.7 ± 4.4% of the recovered dose within this period; the complete excretion profile warrants further investigation at extended time points. These findings provide pharmacokinetic insights into the in vivo fate of marine polysaccharides and support further biological evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Qingdao University, Qingdao 266071, China.
- Qingdao Yihai Industry Holdings Co., Ltd., Qingdao 266105, China.
- Donald Bren School of Information and Computer Sciences, University of California, Irvine, CA 92697, USA.
Förderung
- Taishan Industrial Leading Talents Project-Blue Talent Special (2021)
- Natural Science Foundation of Shandong Province
- Taishan Industrial Leading Talents Project—Blue Talent Special
Zitieren
APA
Liu, M. Y., Yin, D. L., Yu, J., Wang, W. X., Zou, S. C., Zhao, S., Zou, C. Z., Li, F., & Wei, Y. X. (2026). Pharmacokinetic Profiling Evaluation of Ruditapes philippinarum Polysaccharide. Marine Drugs, 24(8), 278. https://doi.org/10.3390/md24080278
Vancouver
Liu MY, Yin DL, Yu J, Wang WX, Zou SC, Zhao S, et al. Pharmacokinetic Profiling Evaluation of Ruditapes philippinarum Polysaccharide. Marine Drugs. 2026;24(8):278. doi:10.3390/md24080278
BibTeX
@article{Liu2026,
author = {Liu, Meng-Yue and Yin, Dong-Li and Yu, Jia and Wang, Wei-Xia and Zou, Sheng-Can and Zhao, Shuang and Zou, Chun-Ze and Li, Fei and Wei, Yu-Xi},
title = {Pharmacokinetic Profiling Evaluation of Ruditapes philippinarum Polysaccharide},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {8},
pages = {278},
doi = {10.3390/md24080278}
}
EUVIMED